Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 274

1.

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.

Qian J, Xie J, Hong S, Yang J, Zhang L, Han X, Wang M, Zhan F, Shaughnessy JD Jr, Epstein J, Kwak LW, Yi Q.

Blood. 2007 Sep 1;110(5):1587-94. Epub 2007 May 21.

PMID:
17515399
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.

Qian J, Wang S, Yang J, Xie J, Lin P, Freeman ME 3rd, Yi Q.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8808-15.

PMID:
16361569
[PubMed - indexed for MEDLINE]
Free Article
3.

Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.

Christensen O, Lupu A, Schmidt S, Condomines M, Belle S, Maier A, Hose D, Neuber B, Moos M, Kleist C, Terness P, Ho AD, Goldschmidt H, Klein B, Hundemer M.

J Immunother. 2009 Jul-Aug;32(6):613-21. doi: 10.1097/CJI.0b013e3181a95198.

PMID:
19483648
[PubMed - indexed for MEDLINE]
4.

Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.

Jalili A, Ozaki S, Hara T, Shibata H, Hashimoto T, Abe M, Nishioka Y, Matsumoto T.

Blood. 2005 Nov 15;106(10):3538-45. Epub 2005 Jul 21.

PMID:
16037388
[PubMed - indexed for MEDLINE]
Free Article
5.

Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.

Qian J, Zheng Y, Zheng C, Wang L, Qin H, Hong S, Li H, Lu Y, He J, Yang J, Neelapu S, Kwak LW, Hou J, Yi Q.

Blood. 2012 Jan 5;119(1):161-9. doi: 10.1182/blood-2011-07-368472. Epub 2011 Nov 2.

PMID:
22049519
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells.

Li Y, Bendandi M, Deng Y, Dunbar C, Munshi N, Jagannath S, Kwak LW, Lyerly HK.

Blood. 2000 Oct 15;96(8):2828-33.

PMID:
11023518
[PubMed - indexed for MEDLINE]
Free Article
7.

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J.

Scand J Immunol. 2009 Apr;69(4):319-28. doi: 10.1111/j.1365-3083.2008.02223.x.

PMID:
19284496
[PubMed - indexed for MEDLINE]
8.

Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk.

Chiriva-Internati M, Wang Z, Xue Y, Bumm K, Hahn AB, Lim SH.

Eur J Immunol. 2001 Aug;31(8):2277-83.

PMID:
11477539
[PubMed - indexed for MEDLINE]
9.

Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.

So T, Hanagiri T, Chapiro J, Colau D, Brasseur F, Yasumoto K, Boon T, Coulie PG.

Cancer Immunol Immunother. 2007 Feb;56(2):259-69. Epub 2006 Jun 7.

PMID:
16758204
[PubMed - indexed for MEDLINE]
10.

MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytes.

Mayr C, Bund D, Schlee M, Bamberger M, Kofler DM, Hallek M, Wendtner CM.

Exp Hematol. 2006 Jan;34(1):44-53.

PMID:
16413390
[PubMed - indexed for MEDLINE]
11.

Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.

Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O.

Exp Hematol. 2006 Apr;34(4):486-96.

PMID:
16569595
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy.

Wen YJ, Min R, Tricot G, Barlogie B, Yi Q.

Blood. 2002 May 1;99(9):3280-5.

PMID:
11964294
[PubMed - indexed for MEDLINE]
Free Article
13.

Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.

Siegel S, Wagner A, Friedrichs B, Wendeler A, Wendel L, Kabelitz D, Steinmann J, Barsoum A, Coggin J, Rohrer J, Dreger P, Schmitz N, Zeis M.

J Immunol. 2006 Jun 1;176(11):6935-44.

PMID:
16709854
[PubMed - indexed for MEDLINE]
Free Article
14.

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor.

Tsukahara T, Kawaguchi S, Torigoe T, Takahashi A, Murase M, Kano M, Wada T, Kaya M, Nagoya S, Yamashita T, Sato N.

J Transl Med. 2009 Jun 12;7:44. doi: 10.1186/1479-5876-7-44.

PMID:
19523231
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28.

Han JF, Zhao TT, Liu HL, Lin ZH, Wang HM, Ruan ZH, Zou LY, Wu YZ.

Cancer Immunol Immunother. 2006 Dec;55(12):1575-83. Epub 2006 Mar 14.

PMID:
16534571
[PubMed - indexed for MEDLINE]
17.

Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.

Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

Cancer. 2009 Feb 15;115(4):800-11. doi: 10.1002/cncr.24048.

PMID:
19117353
[PubMed - indexed for MEDLINE]
Free Article
18.

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.

Batchu RB, Moreno AM, Szmania SM, Bennett G, Spagnoli GC, Ponnazhagan S, Barlogie B, Tricot G, van Rhee F.

Cancer Res. 2005 Nov 1;65(21):10041-9.

PMID:
16267030
[PubMed - indexed for MEDLINE]
Free Article
19.

Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses.

Breckpot K, Heirman C, De Greef C, van der Bruggen P, Thielemans K.

J Immunol. 2004 Feb 15;172(4):2232-7.

PMID:
14764691
[PubMed - indexed for MEDLINE]
Free Article
20.

CD23 is recognized as tumor-associated antigen (TAA) in B-CLL by CD8+ autologous T lymphocytes.

Bund D, Mayr C, Kofler DM, Hallek M, Wendtner CM.

Exp Hematol. 2007 Jun;35(6):920-30.

PMID:
17533046
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk